Drug recall
oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa…
FDA recall event 85773 · Class II · QuVa Pharma, Inc.
Key facts
| Event ID | 85773 |
|---|---|
| Recall numbers | D-1302-2020 |
| Recalling firm | QuVa Pharma, Inc. |
| Product type | Drugs |
| Products | oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Subpotent drug - Product did not contain drug. |
| Initiation date | May 28, 2020 |
| Report date | Jun 17, 2020 |
| Termination date | Jan 19, 2022 |
| City | Sugar Land |
| State | TX |
| Country | United States |
| FEI number | 3012053582 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: